| Primary |
| Muscle Spasms |
50.0% |
| Oropharyngeal Pain |
50.0% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
28.3% |
| Plasmodium Falciparum Infection |
17.4% |
| Asthma |
13.0% |
| Blood Cholesterol Increased |
10.9% |
| Arthritis |
8.7% |
| Muscle Spasms |
8.7% |
| Hypertension |
6.5% |
| Pancreatic Disorder |
4.3% |
| Blood Pressure High |
2.2% |
|
| Pneumonia Pneumococcal |
27.3% |
| Product Substitution Issue |
27.3% |
| Vomiting |
18.2% |
| Neck Pain |
9.1% |
| Pyrexia |
9.1% |
| Rhabdomyolysis |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.1% |
| Drug Use For Unknown Indication |
12.7% |
| Hypertension |
7.3% |
| Muscle Spasms |
5.5% |
| Pain |
4.5% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Rheumatoid Arthritis |
2.0% |
| Renal Failure |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Cardiac Disorder |
1.6% |
| Prophylaxis |
1.6% |
| Anaemia |
1.4% |
| Diabetes Mellitus |
1.4% |
| Nausea |
1.4% |
| Oedema |
1.4% |
| Depression |
1.3% |
| Obesity |
1.3% |
| Back Pain |
1.2% |
| Breast Cancer |
1.2% |
| Anxiety |
1.1% |
|
| Weight Increased |
14.4% |
| Renal Failure Acute |
13.5% |
| Vomiting |
9.0% |
| Gastrointestinal Haemorrhage |
7.2% |
| Hypomagnesaemia |
5.4% |
| Renal Impairment |
5.4% |
| Syncope |
4.5% |
| Serotonin Syndrome |
3.6% |
| Therapeutic Response Decreased |
3.6% |
| Transplant Rejection |
3.6% |
| Treatment Failure |
3.6% |
| Urinary Incontinence |
3.6% |
| Vertigo |
3.6% |
| Angina Pectoris |
2.7% |
| Gastric Ulcer |
2.7% |
| Hypoglycaemia |
2.7% |
| Left Ventricular Dysfunction |
2.7% |
| Malaise |
2.7% |
| Melaena |
2.7% |
| Muscle Disorder |
2.7% |
|
| Interacting |
| Convulsion |
33.3% |
| Epilepsy |
33.3% |
| Plasmodium Falciparum Infection |
33.3% |
|
|
